The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Changing chemotherapy (C) with concurrent radiation (RT) followed by surgery after sub-optimal FDG-PET response to induction chemotherapy improves outcomes in locally advanced (LA) esophageal adenocarcinoma (EA).
 
Anuja Kriplani
No Relationships to Disclose
 
Yelena Yuriy Janjigian
Consulting or Advisory Role - Lilly
Research Funding - Bayer; Boehringer Ingelheim
 
David Paul Kelsen
No Relationships to Disclose
 
Valerie W. Rusch
No Relationships to Disclose
 
Manjit S. Bains
No Relationships to Disclose
 
Nabil P. Rizk
No Relationships to Disclose
 
Joanne F. Chou
No Relationships to Disclose
 
Marinela Capanu
No Relationships to Disclose
 
Abraham Jing-Ching Wu
Consulting or Advisory Role - Pfizer
 
Karyn A. Goodman
Consulting or Advisory Role - Pfizer
 
David H. Ilson
Consulting or Advisory Role - Amgen; Lilly/ImClone; Roche/Genentech
Speakers' Bureau - Genentech/Roche
Research Funding - Amgen; Bayer; Bristol-Myers Squibb
Travel, Accommodations, Expenses - Amgen; Genentech/Roche
 
Geoffrey Yuyat Ku
Research Funding - Amgen; Bristol-Myers Squibb
Travel, Accommodations, Expenses - Amgen